Related references
Note: Only part of the references are listed.Cathepsin L, target in cancer treatment?
Jacqueline M. Lankelma et al.
LIFE SCIENCES (2010)
The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts
Sara Bhana et al.
MUTAGENESIS (2008)
Cysteine Cathepsins and the cutting edge of cancer invasion
Vasilena Gocheva et al.
CELL CYCLE (2007)
Wild-type p53 inhibits nuclear factor-κB-Induced matrix metalloproteinase-9 promoter activation:: Implications for soft tissue sarcoma growth and metastasis
Jue Liu et al.
MOLECULAR CANCER RESEARCH (2006)
Antiangiogenic activity of BAI1 in vivo:: implications for gene therapy of human glioblastomas
X Kang et al.
CANCER GENE THERAPY (2006)
Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms
D Jean et al.
ONCOGENE (2006)
Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status
H Ito et al.
HUMAN GENE THERAPY (2005)
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
A Willis et al.
ONCOGENE (2004)
C/EBPα is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes
K Yoon et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment
N Rousselet et al.
CANCER RESEARCH (2004)
Transcription of human cathepsin L mRNA species hCATL B from a novel alternative promoter in the first intron of its gene
P Seth et al.
GENE (2003)
Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis
N Levicar et al.
CANCER GENE THERAPY (2003)
Identification and characterization of a novel human cathepsin L splice variant
S Arora et al.
GENE (2002)
Neuronal loss and brain atrophy in mice lacking cathepsins B and L
U Felbor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling
DJ Tobin et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity
D Jean et al.
BIOCHEMICAL JOURNAL (2002)
Cloning and characterization of human cathepsin L promoter
R Bakhshi et al.
GENE (2001)
Apoptotic death of inflammatory cells in human atheroma
W Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
The CD4 T cell-deficient mouse mutation nackt (nkt) involves a deletion in the cathepsin L (Ctsl) gene
F Benavides et al.
IMMUNOGENETICS (2001)
p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma
G Fulci et al.
ONCOGENE (2000)
The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis
RD Meng et al.
MOLECULAR THERAPY (2000)
Share Paper
